Hong Kong Stock Movement | Hiber Healthcare-B (02142.HK) surged over 7% in early trading as its revenue increased and it turned a profit in the first half of the year. Recently, it has entered into a strategic partnership with China National Pharmaceutical Group.
Zhitong Finance APP has reported that Heber Pharmaceuticals-B (02142.HK) rose over 7% in early trading. As of the time of writing, it has increased by 7.23%, priced at HKD 13.65, with a trading volume of HKD 34.0336 million.
Latest
